ImmuPharma (LON:IMM) Stock Price Up 18.6% – What’s Next?

Shares of ImmuPharma plc (LON:IMM) rose 18.6% on Thursday . The stock traded as high as GBX 4.50 ($0.06) and last traded at GBX 3.98 ($0.05). Approximately 6,527,307 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 13,541,125 shares. The stock had previously closed at GBX 3.36 ($0.04).

ImmuPharma Trading Up 18.6 %

The firm has a market cap of £16.91 million, a P/E ratio of -6.88 and a beta of 1.53. The business has a 50-day moving average price of GBX 3.72 and a 200-day moving average price of GBX 2.30.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.